Farolfi Alberto, Ferrario Cristiano, Aquilina Michele, Cecconetto Lorenzo, Tartaglia Andreas, Ibrahim Toni, Serra Luigi, Oboldi Devil, Nizzoli Maurizio, Rocca Andrea
Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola (FC), Italy.
Cardiology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola (FC), Italy.
Oncol Lett. 2015 Aug;10(2):773-777. doi: 10.3892/ol.2015.3326. Epub 2015 Jun 5.
Hypocalcemia is an uncommon clinical symptom of patients with malignant tumors, and a number of factors may be involved in its development. The present study describes the case of a 67-year-old Caucasian female, presenting with severe refractory hypocalcemia and heart failure. The patient was subsequently diagnosed with breast cancer and bone metastases. The paraneoplastic origin of the syndrome was confirmed by its complete resolution once the tumor responded to specific antineoplastic treatments, comprising weekly paclitaxel and aromatase inhibitor administration. The present case report suggested the need for greater awareness of the possibility of paraneoplastic hypocalcemia in breast cancer patients, and suggested that this condition may also contribute to the occurrence of heart failure. The mechanisms potentially responsible for this event were discussed and a brief review of the literature presented.
低钙血症是恶性肿瘤患者中不常见的临床症状,其发生可能涉及多种因素。本研究描述了一名67岁白种女性的病例,该患者出现严重难治性低钙血症和心力衰竭。患者随后被诊断为乳腺癌并伴有骨转移。一旦肿瘤对包括每周一次紫杉醇和芳香化酶抑制剂给药的特定抗肿瘤治疗产生反应,该综合征的副肿瘤起源通过其完全缓解得到证实。本病例报告提示需要提高对乳腺癌患者发生副肿瘤性低钙血症可能性的认识,并提示这种情况也可能导致心力衰竭的发生。讨论了可能导致这一事件的机制,并对文献进行了简要综述。